Skip to main content
OpenTrials

Clinical trial condition

Latent Tuberculosis Infection

Explore clinical trials studying Latent Tuberculosis Infection. Study availability and eligibility vary by location and protocol.

27 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Latent Tuberculosis Infection trial results

Completed

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

NCT01136161

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations
  • Parexel Int. Bloemfontein Bloemfontein, South Africa
  • Parexel Int. George George, South Africa
  • Parexel Int. Port Elizabeth Port Elizabeth, South Africa
View Trial Details
Completed

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

NCT00546273

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations
  • Experimental Tuberculosis Unit. Fundació Institut per la Investigació Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Pharmacology Department. Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain
View Trial Details

Related conditions